Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
Not Applicable
Completed
- Conditions
- HirsutismMenstrual ProblemPolycystic Ovary Syndrome
- Interventions
- Dietary Supplement: Myo-inositol+L-tyrosine
- Registration Number
- NCT03673995
- Lead Sponsor
- Pharmarte srl
- Brief Summary
PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal evaluation , hirsutism scoring and ovulation assesment. Most of them during the treatment improved their symptoms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 186
Inclusion Criteria
° PCOS patients
Exclusion Criteria
- thyroid dysfunction
- hyperprolactinemia
- adrenal hyperplasia
- patients taking oral contraceptive
- any other endocrinological pathologies
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Myo-inositol+L-tyrosine Myo-inositol+L-tyrosine One sachet per day containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid for improving PCOS symptoms.
- Primary Outcome Measures
Name Time Method Restore of regular menstrual period 6 months of treatment Self report
- Secondary Outcome Measures
Name Time Method Restore ovulation 6 months of treatment Progesterone value in luteal phase
Improving hirsutism 6 months of treatment Standardised visual scales are preferred when assessing hirsutism, such as the modified Ferriman Gallwey score (mFG) with a level ≥ 4 - 6 indicating hirsutism,
Trial Locations
- Locations (1)
Altamedica Reproductive Medicine
🇮🇹Roma, Italy